Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)

Clinical trial NCT02773225 · COMPLETED

Trial details

NCT number: NCT02773225
Sponsor: B. Höchsmann
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Anemia, Aplastic

Start date: 2015-01-27
Primary completion: 2025-01-30
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.